Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Daniel Mullins

Showing results (161-170 of 333) with videos related to

Pageof 34
Sort By:
Pain Reports|June 9, 2021
Veteran engagement in opioid tapering research: a mission to optimize pain managementLuana Colloca, Nkaku R Kisaalita, Marcel Bizien, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
Future of Patients in Healthcare Evaluation: The Patient-Informed Reference CaseJulia F Slejko, T Joseph Mattingly, C Daniel Mullins, et al.
American Journal of Pharmaceutical Education|May 9, 2019
A Systematic Review of Entrepreneurship in Pharmacy Practice and EducationT Joseph Mattingly, C Daniel Mullins, Diamond R Melendez, et al.
The American Journal of Geriatric Pharmacotherapy|February 5, 2010
Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancerNour A Obeidat, Françoise G Pradel, Ilene H Zuckerman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 15, 2005
An economic evaluation of triptan products for migraineEleanor M Perfetto, Kathleen A Weis, C Daniel Mullins, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 6, 2005
Health disparities: a barrier to high-quality careC Daniel Mullins, Lisa Blatt, Confidence M Gbarayor, et al.
The Patient|July 27, 2019
What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and AltruismT Joseph Mattingly, Julia F Slejko, Eleanor M Perfetto, et al.
Contemporary Clinical Trials Communications|July 21, 2020
Site engagement for multi-site clinical trialsDana Goodlett, Anna Hung, Ashley Feriozzi, et al.
Cancer|June 26, 2014
Racial disparities in urologist visits among elderly men with prostate cancer: a cohort analysis of patient-related and county of residence-related factorsEberechukwu Onukwugha, Phillip Osteen, Jinani Jayasekera, et al.
Cancer Medicine|January 10, 2014
Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patientsZhiyuan Zheng, Nader Hanna, Eberechukwu Onukwugha, et al.
Pageof 34

Showing results (161-170 of 333) with videos related to

Sort By:
Pageof 34
Pain Reports|June 9, 2021
Veteran engagement in opioid tapering research: a mission to optimize pain managementLuana Colloca, Nkaku R Kisaalita, Marcel Bizien, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
Future of Patients in Healthcare Evaluation: The Patient-Informed Reference CaseJulia F Slejko, T Joseph Mattingly, C Daniel Mullins, et al.
American Journal of Pharmaceutical Education|May 9, 2019
A Systematic Review of Entrepreneurship in Pharmacy Practice and EducationT Joseph Mattingly, C Daniel Mullins, Diamond R Melendez, et al.
The American Journal of Geriatric Pharmacotherapy|February 5, 2010
Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancerNour A Obeidat, Françoise G Pradel, Ilene H Zuckerman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 15, 2005
An economic evaluation of triptan products for migraineEleanor M Perfetto, Kathleen A Weis, C Daniel Mullins, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 6, 2005
Health disparities: a barrier to high-quality careC Daniel Mullins, Lisa Blatt, Confidence M Gbarayor, et al.
The Patient|July 27, 2019
What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and AltruismT Joseph Mattingly, Julia F Slejko, Eleanor M Perfetto, et al.
Contemporary Clinical Trials Communications|July 21, 2020
Site engagement for multi-site clinical trialsDana Goodlett, Anna Hung, Ashley Feriozzi, et al.
Cancer|June 26, 2014
Racial disparities in urologist visits among elderly men with prostate cancer: a cohort analysis of patient-related and county of residence-related factorsEberechukwu Onukwugha, Phillip Osteen, Jinani Jayasekera, et al.
Cancer Medicine|January 10, 2014
Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patientsZhiyuan Zheng, Nader Hanna, Eberechukwu Onukwugha, et al.
Pageof 34